TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 2 | 3 | 13 | 49 | 88 | -22 | 22 |
| P | %wins | 100 | 67 | 67 | 33 | 50 | 0 | 53 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/20/11 17:34 | 9/19/11 | TSPT | Transcept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Oclassen Glenn A | CA | DO | P,CEO | P | 116 | 5.80 | 3 | 20 | 5 | 384 | M | -55 | -23 | -33 | -45 | 105 | 97 | 103 | 69 | 1 | -6 | 2 | -1 | ||
8/11/11 12:51 | 8/10/11 | TSPT | Transcept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Oclassen Glenn A | CA | DO | P,CEO | P.m | 85 | 2.82 | 1 | 30 | 9 | 364 | D | -68 | -62 | -65 | -72 | -74 | -37 | -29 | -11 | 4 | 6 | -3 | 191 | 190 | |
8/21/09 19:49 | 8/21/09 | TSPT | Transcept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Oclassen Glenn A | CA | DO | P,CEO | P | 83 | 9.50 | 1 | 9 | 10 | 99 | D | 158 | 76 | 92 | 56 | 4 | 1 | 2 | 10 | 40 | -43 | -15 | -22 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |